The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients-Reference-Cited by-同舟云学术

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients

Published:2021-09-30 Issue:3 Volume:56 Page:156-165
ISSN:2287-979X
Container-title:BLOOD RESEARCH
language:en
Short-container-title:Blood Res

Author:

Shires Karen¹,Wyk Teagan Van²,Wienand Kirsty³

Affiliation:

1. Division of Haematology, Department of Pathology, University of Cape Town and National Health Laboratory Service/Groote Schuur Hospital, South Africa

2. Department of Medicine, University of Cape Town, Cape Town, South Africa

3. Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Funder

National Health Laboratory Research Trust

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://pdf.medrang.co.kr/BR/2021/056/BR056-03-156.pdf

Reference35 articles.

1. New criteria for response assessment: role of minimal residual disease in multiple myeloma

2. Treatment options for relapsed and refractory multiple myeloma

3. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

4. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

5. Guidelines for Clinical and Laboratory Evaluation of Patients With Monoclonal Gammopathies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED);Clinical Epigenetics;2024-02-27